Literature DB >> 6982272

Immature megakaryocytes in the mouse: in vitro relationship to megakaryocyte progenitor cells and mature megakaryocytes.

M W Long, N Williams, T P McDonald.   

Abstract

An assay describing conditions for the maturation of single immature megakaryocytes in vitro is reported. Enriched populations of small, relatively immature megakaryocytes have been found to develop into single, mature megakaryocytes by 60 hours in semisolid agar cultures. Continued incubation of these cells did not lead to the formation of colonies within 5-7 days. Maturation was indicated by increasing cell size and cytoplasmic and acetylcholinesterase content. Factors stimulating the development of immature megakaryocytes were found in preparations of human embryonic kidney cell-conditioned media (a source of in vivo Thrombopoietic Stimulatory Factor), peritoneal exudate cell-conditioned medium, lung-conditioned medium, or bone marrow cellular sources of activity (adherent cells or cells that sediment at 5-6 mm hr-1). Immature megakaryocytes cultured serum free responded to sources of an auxiliary megakaryocyte potentiating activity by developing into single, large megakaryocytes but did not respond to a megakaryocyte colony-stimulating factor devoid of detectable potentiator activity present in WEH1-3-conditioned medium. In contrast, serum-free proliferation of the megakaryocyte progenitor cell required both megakaryocyte colony-stimulating factor and the auxiliary potentiator activity. In the presence of megakaryocyte colony-stimulating factor alone, progenitor cells did not form colonies of easily detectable megakaryocytes. However, groups of cells comprised entirely of small acetylcholinesterase containing immature megakaryocytes were observed, thus establishing that megakaryocyte colony development passes through a stage of immature cells prior to detectable megakaryocyte development and that some acetylcholinesterase-containing cells can undergo cellular division.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982272     DOI: 10.1002/jcp.1041120305

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.

Authors:  T Ishibashi; H Kimura; T Uchida; S Kariyone; P Friese; S A Burstein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Role of phorbol diesters in in vitro murine megakaryocyte colony formation.

Authors:  M W Long; J E Smolen; P Szczepanski; L A Boxer
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

3.  Synergistic regulation of human megakaryocyte development.

Authors:  M W Long; R J Hutchinson; L L Gragowski; C H Heffner; S G Emerson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Characterization of mouse clonogenic megakaryocyte progenitors.

Authors:  Thanyaphong Na Nakorn; Toshihiro Miyamoto; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

5.  Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content.

Authors:  N S Datta; J L Williams; J Caldwell; A M Curry; E K Ashcraft; M W Long
Journal:  Mol Biol Cell       Date:  1996-02       Impact factor: 4.138

6.  Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin 3.

Authors:  B E Robinson; H E McGrath; P J Quesenberry
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis.

Authors:  Y Nagata; Y Muro; K Todokoro
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

8.  Immune regulation of in vitro murine megakaryocyte development. Role of T lymphocytes and Ia antigen expression.

Authors:  M W Long; D N Shapiro
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.